Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.



person default
Marion Elligsen, BScPhm, MSc, RPh, ACPR
Keith S. Kaye, MD, MPH
Andrew Shorr, MD, MPH, MBA
Released: November 16, 2022

Information on this Educational Activity


Marion Elligsen, BScPhm, MSc, RPh, ACPR

Practice-Based Researcher
Sunnybrook Research Institute
Antimicrobial Stewardship Pharmacy Lead
Department of Pharmacy
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada

Marion Elligsen, BScPhm, MSc, RPh, ACPR, has no relevant financial relationships to disclose.
Keith S. Kaye, MD, MPH

Division of Allergy, Immunology and Infectious Diseases
Professor of Medicine
Rutgers Robert Wood Johnson Medical School
New Brunswick, New Jersey

Keith S. Kaye, MD, MPH: consultant/advisor/speaker: Actavis, Allecra, Bayer, Carb-X, Cipla, Clarametyx, ContraFect, Cubist, Entasis, GlaxoSmithKline, Integrated Operations, Melinta, Merck, MicuRx, Nabriva, NS Nanotech, Pratek, Qpex, Shionogi, Spero, Utility, Venatorx, Xellia.
Andrew Shorr, MD, MPH, MBA

Director, Pulmonary and Critical Care Medicine
Washington, DC

Andrew Shorr, MD, MPH, MBA: consultant/advisor/speaker: Merck, Pfizer,Shionogi.

Program Medium

This program has been made available online.

Related Content

Expert faculty discuss ways to improve the empiric treatment of HABP/VABP in the ICU in this commentary from Clinical Care Options (CCO)

person default Marion Elligsen, BScPhm, MSc, RPh, ACPR Keith S. Kaye, MD, MPH Andrew Shorr, MD, MPH, MBA Released: November 18, 2022

Learn from experts about strategies to improve timely, effective antibiotic therapy in patients with HABP/VABP at risk for multidrug resistance, from Clinical Care Options (CCO)

Clinical Care Options (CCO) presents expert faculty discussing RSV in certain adult populations and the development of RSV vaccines

John J. Russell, MD, FAAFP
Program Director
Laura Hurley, MD, MPH Pamela Rockwell, DO, FAAFP
Physicians: maximum of 1.5 AMA PRA Category 1 Credits Registered Nurses: 1.5 Nursing contact hours Released: October 28, 2022 Expired: October 27, 2023

Video Chapters

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Merck Sharp & Dohme LLC

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Cookie Settings